Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series

Therapy for leptomeningeal metastases (LM) from non-small cell lung cancer (NSCLC) is challenging, and conventional treatments have little impact on the disease course. We report three cases that were definitively diagnosed as LM from NSCLC with a mutation of epidermal growth factor receptor (EGFR)...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Onco Targets Ther
Main Authors: Li, Huiying, Yu, Tingting, Huang, Mingmin, Guo, Aibin, Qian, Xiaoping, Yin, Zhenyu
Format: Artigo
Jezik:Inglês
Izdano: Dove 2019
Teme:
Case Series
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6759207/
https://ncbi.nlm.nih.gov/pubmed/31571928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S199452
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki